| Literature DB >> 34723753 |
Masaki Machida1,2, Itaru Nakamura2, Takako Kojima3, Reiko Saito4, Tomoki Nakaya5, Tomoya Hanibuchi5, Tomoko Takamiya1, Yuko Odagiri1, Noritoshi Fukushima1, Hiroyuki Kikuchi1, Shiho Amagasa1, Hidehiro Watanabe2, Shigeru Inoue1.
Abstract
Vaccine hesitancy regarding the coronavirus disease 2019 (COVID-19) vaccine is widespread during the COVID-19 pandemic. Many recent studies have reported that the confidence of the vaccination and perceived risk were associated with vaccination intent, yet few studies have focused on other psychological factors. This study aimed to clarify the trends in COVID-19 vaccination intent and to identify the association between the 5C psychological antecedents and COVID-19 vaccination intent by sex and age in Japan. This was a longitudinal study conducted through an Internet-based survey from January 2021 to April 2021 before and after vaccine distribution in Japan, including 2,655 participants recruited by quota sampling. Participants were asked to indicate how likely they were to get vaccinated against COVID-19. In the second survey, the participants responded to questions regarding the 5C psychological antecedents: confidence, complacency, constraints (structural and psychological barriers), calculation (engagement in extensive information searching), and collective responsibility (willingness to protect others). Multiple logistic regression analysis was performed to clarify the association between the 5C psychological antecedents and COVID-19 vaccination intent in the second wave survey. COVID-19 vaccination intent improved from 62.1% to 72.4% after vaccine distribution, but no significant difference was found in young men. Confidence and collective responsibility were positively associated with vaccination intent, and calculation was negatively associated among all generations. COVID-19 vaccination intent may be affected not only by confidence and constraints but also by calculation and collective responsibility, and further research is needed.Entities:
Keywords: Coronavirus disease; epidemiology; personal protective measure; public health; vaccine hesitancy
Mesh:
Substances:
Year: 2021 PMID: 34723753 PMCID: PMC8828139 DOI: 10.1080/21645515.2021.1968217
Source DB: PubMed Journal: Hum Vaccin Immunother ISSN: 2164-5515 Impact factor: 3.452
Participants’ characteristics
| Men | Women | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20–39 years | 40–59 years | 60–79 years | 20–39 years | 40–59 years | 60–79 years | |||||||
| N= 353 | N= 527 | N= 435 | N= 367 | N= 495 | N= 478 | |||||||
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |||||||
| Marital status | ||||||||||||
| Married | 90 | (25.5) | 296 | (56.2) | 348 | (80.0) | 127 | (34.6) | 337 | (68.1) | 360 | (75.3) |
| Not married | 263 | (74.5) | 231 | (43.8) | 87 | (20.0) | 240 | (65.4) | 158 | (31.9) | 118 | (24.7) |
| Employment status | ||||||||||||
| Working | 279 | (79.0) | 475 | (90.1) | 222 | (51.0) | 253 | (68.9) | 287 | (58.0) | 103 | (21.5) |
| Not working | 74 | (21.0) | 52 | (9.9) | 213 | (49.0) | 114 | (31.1) | 208 | (42.0) | 375 | (78.5) |
| Residential area | ||||||||||||
| Tokyo metropolitan areaa | 103 | (29.2) | 175 | (33.2) | 134 | (30.8) | 118 | (32.2) | 151 | (30.5) | 155 | (32.4) |
| Other | 250 | (70.8) | 352 | (66.8) | 301 | (69.2) | 249 | (67.8) | 344 | (69.5) | 323 | (67.6) |
| Living arrangement | ||||||||||||
| Alone | 99 | (28.0) | 109 | (20.7) | 61 | (14.0) | 65 | (17.7) | 56 | (11.3) | 83 | (17.4) |
| With others | 254 | (72.0) | 418 | (79.3) | 374 | (86.0) | 302 | (82.3) | 439 | (89.7) | 395 | (82.6) |
| Educational attainment | ||||||||||||
| University graduate or above | 248 | (70.3) | 329 | (62.4) | 284 | (65.3) | 228 | (62.1) | 181 | (36.6) | 118 | (24.7) |
| Below university graduate level | 105 | (29.7) | 198 | (37.6) | 151 | (34.7) | 139 | (37.9) | 314 | (63.4) | 360 | (75.3) |
| Annual personal income | ||||||||||||
| <2 million yen [approximately 19,000 USD] | 123 | (34.8) | 87 | (16.5) | 93 | (21.4) | 210 | (57.2) | 366 | (73.9) | 385 | (80.5) |
| 2-<4 million yen [19,000 -< 38,000] | 96 | (27.2) | 114 | (21.6) | 202 | (46.4) | 114 | (31.1) | 87 | (17.6) | 70 | (14.6) |
| 4-<6 million yen [38,000 -< 57,000] | 92 | (26.1) | 136 | (25.8) | 89 | (20.5) | 28 | (7.6) | 34 | (6.9) | 14 | (2.9) |
| ≥6 million yen or more [57,000-] | 42 | (11.9) | 190 | (36.1) | 51 | (11.7) | 15 | (4.1) | 8 | (1.6) | 9 | (1.9) |
| Underlying diseasesb | ||||||||||||
| Yes | 49 | (13.9) | 143 | (27.1) | 249 | (57.2) | 27 | (7.4) | 92 | (18.6) | 194 | (40.6) |
| No | 304 | (86.1) | 384 | (72.9) | 186 | (42.8) | 340 | (92.6) | 403 | (81.4) | 284 | (59.4) |
aTokyo metropolitan area included Tokyo, Kanagawa, Saitama, and Chiba prefectures.
bUnderlying diseases included heart disease, respiratory disease, kidney disease, diabetes, and hypertension.
Figure 1.The proportion of participants who had COVID-19 vaccination intent during the baseline (January 2021) and second wave (April 2021) surveys. The McNemar test was performed to compare the prevalence (* p value < .05, ** p value < .001).
Mean value of 5C psychological antecedents for age, sex, and vaccination intent
| Total | Participants having COVID-19 vaccination intent a | Participants not having COVID-19 vaccination intent | Total | Participants having COVID-19 vaccination intent | Participants not having COVID-19 vaccination intent | Total | Participants having COVID-19 vaccination intent | Participants not having COVID-19 vaccination intent | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Men | ||||||||||||
| 20–39 years | 40–59 years | 60–79 years | ||||||||||
| n | 353 | 222 | 131 | 527 | 358 | 169 | 435 | 399 | 36 | |||
| (%) | (62.9) | (37.1) | (67.9) | (32.1) | (91.7) | (9.3) | ||||||
| Mean | Mean | Mean | Mean | Mean | Mean | Mean | Mean | Mean | ||||
| | (SD) | (SD) | (SD) | p-value c | (SD) | (SD) | (SD) | p-value | (SD) | (SD) | (SD) | p-value |
| Confidence b | 4.42 | 4.81 | 3.77 | <0.001 | 4.32 | 4.73 | 3.46 | <0.001 | 4.95 | 5.05 | 3.85 | <0.001 |
| (1.06) | (0.90) | (0.99) | (1.15) | (0.95) | (1.05) | (0.95) | (0.88) | (0.98) | ||||
| Complacency b | 3.31 | 2.99 | 3.85 | <0.001 | 2.90 | 2.57 | 3.60 | <0.001 | 2.56 | 2.44 | 3.90 | <0.001 |
| (1.34) | (1.39) | (1.08) | (1.25) | (1.16) | (1.16) | (1.19) | (1.11) | (1.19) | ||||
| Constraints b | 3.64 | 3.32 | 4.19 | <0.001 | 3.28 | 3.00 | 3.87 | <0.001 | 2.51 | 2.38 | 3.99 | <0.001 |
| (1.26) | (1.31) | (0.94) | (1.15) | (1.16) | (0.86) | (1.17) | (1.10) | (0.91) | ||||
| Calculation b | 4.70 | 4.73 | 4.66 | 0.478 | 4.75 | 4.77 | 4.71 | 0.574 | 4.83 | 4.78 | 5.37 | 0.002 |
| (0.94) | (0.91) | (0.97) | (1.07) | (1.07) | (1.07) | (1.09) | (1.08) | (1.02) | ||||
| Collective responsibility b | 4.73 | 5.14 | 4.03 | <0.001 | 4.99 | 5.47 | 3.99 | <0.001 | 5.57 | 5.73 | 3.89 | <0.001 |
| | (1.08) | (1.06) | (0.68) | | (1.19) | (1.02) | (0.86) | | (1.07) | (0.93) | (1.05) | |
| Women | ||||||||||||
| 20–39 years | 40–59 years | 60–79 years | ||||||||||
| n | 367 | 212 | 155 | 495 | 323 | 172 | 478 | 408 | 70 | |||
| (%) | (57.8) | (42.2) | (65.3) | (34.7) | (85.4) | (14.6) | ||||||
| Mean | Mean | Mean | Mean | Mean | Mean | Mean | Mean | Mean | ||||
| | (SD) | (SD) | (SD) | p-value c | (SD) | (SD) | (SD) | p-value | (SD) | (SD) | (SD) | p-value |
| Confidence | 4.20 | 4.68 | 3.55 | <0.001 | 4.34 | 4.70 | 3.66 | <0.001 | 4.87 | 5.06 | 3.70 | <0.001 |
| (1.04) | (0.84) | (0.93) | (1.01) | (0.79) | (1.01) | (0.94) | (0.79) | (0.92) | ||||
| Complacency | 3.16 | 2.95 | 3.44 | <0.001 | 2.98 | 2.64 | 3.61 | <0.001 | 2.62 | 2.43 | 3.70 | <0.001 |
| (1.13) | (1.21) | (0.94) | (1.17) | (1.12) | (1.00) | (1.13) | (1.03) | (1.08) | ||||
| Constraints | 3.52 | 3.28 | 3.84 | <0.001 | 3.27 | 2.96 | 3.85 | <0.001 | 2.63 | 2.43 | 3.80 | <0.001 |
| (1.09) | (1.15) | (0.90) | (1.18) | (1.21) | (0.87) | (1.13) | (1.05) | (0.84) | ||||
| Calculation | 4.84 | 4.88 | 4.78 | 0.368 | 5.01 | 4.89 | 5.23 | <0.001 | 5.07 | 5.05 | 5.18 | 0.310 |
| (1.05) | (1.01) | (1.10) | (0.95) | (0.85) | (1.08) | (0.99) | (0.97) | (1.11) | ||||
| Collective responsibility | 4.77 | 5.27 | 4.09 | <0.001 | 5.00 | 5.51 | 4.05 | <0.001 | 5.54 | 5.80 | 4.01 | <0.001 |
| (1.06) | (0.97) | (0.77) | (1.14) | (0.92) | (0.87) | (1.07) | (0.87) | (0.77) | ||||
SD: standard deviation
aWe defined “a participant having COVID-19 vaccination intent” as meeting one of the following two criteria; 1) pertaining to the question on how likely they were to get vaccinated for COVID-19, the participant responded “very likely” or “somewhat likely, 2) pertaining to the question on whether they planned to be vaccinated or not, the participant responded “yes” or “already vaccinated”.
bAverage of the three subscales.
cp-value was calculated using t test.
Individual psychological factors associated with COVID-19 vaccination intent
| Odds ratioa | 95% confidence interval | p-value | Odds ratio | 95% confidence interval | p-value | Odds ratio | 95% confidence interval | p-value | |
|---|---|---|---|---|---|---|---|---|---|
| Men | |||||||||
| | 20–39 years | 40–59 years | 60–79 years | ||||||
| Confidence | 3.90 | (2.45-6.22) | <0.001 | 3.16 | (2.16-4.61) | <0.001 | 2.47 | (1.21-5.06) | 0.014 |
| Complacency | 0.79 | (0.55-1.12) | 0.187 | 0.83 | (0.59-1.16) | 0.266 | 1.18 | (0.63-2.22) | 0.600 |
| Constraints | 0.66 | (0.44-0.99) | 0.043 | 0.69 | (0.47-1.00) | 0.048 | 0.38 | (0.21-0.71) | 0.002 |
| Calculation | 0.55 | (0.36-0.84) | 0.006 | 0.50 | (0.35-0.70) | <0.001 | 0.24 | (0.12-0.47) | <0.001 |
| Collective responsibility | 3.48 | (2.02-5.97) | <0.001 | 4.92 | (2.90-8.36) | <0.001 | 7.49 | (2.81-20.00) | <0.001 |
| Women | |||||||||
| | 20–39 years | 40–59 years | 60–79 years | ||||||
| Confidence | 4.53 | (2.69-7.64) | <0.001 | 3.32 | (2.15-5.12) | <0.001 | 4.80 | (2.39-9.63) | <0.001 |
| Complacency | 1.17 | (0.78-1.74) | 0.451 | 0.81 | (0.56-1.16) | 0.249 | 0.71 | (0.40-1.25) | 0.236 |
| Constraints | 0.69 | (0.44-1.08) | 0.100 | 1.10 | (0.76-1.59) | 0.601 | 0.91 | (0.49-1.70) | 0.771 |
| Calculation | 0.41 | (0.27-0.61) | <0.001 | 0.31 | (0.20-0.46) | <0.001 | 0.52 | (0.33-0.83) | 0.006 |
| Collective responsibility | 5.48 | (2.93-10.23) | <0.001 | 8.82 | (5.01-15.51) | <0.001 | 9.09 | (4.24-19.48) | <0.001 |
The dependent variable was set as a dichotomous variable coded as “1” if the participant had COVID-19 vaccination intent in the second wave survey and “zero” otherwise. The independent variable was the mean score of the five psychological antecedents.
All variables were placed in the model simultaneously, and the model was adjusted for educational attainment (university graduate or above/below) and annual personal income (<19,000 USD /19,000–38,000 /38,000–57,000/≥57,000).